List of Figures:
Figure 4-1: Worldwide Value of Bioinformatics Market ($ Million), 2002-2005
Figure 4-2: US - Bioinformatics Market ($ Million), 2002-2005
Figure 4-3: US - Funding for the Microbial Genome Project ($ Million), 1997-2004
Figure 4-4: Europe - Bio-Informatics Market ($ Million), 2002-2005
Figure 4-5: Europe - Total Research and Development Funding and Drugs in Pipeline, By Company Size (%), 2004
Figure 4-6: Asia Pacific - Bioinformatics Market ($ Million), 2002-2005
Figure 4-7: Worldwide Pharmacogenomics Market (%), 2008
Figure 4-8: Worldwide DNA Sequencing and Proteomics Market ($ Billion), 2004-2009
Figure 4-9: Worldwide Genomics Market ($ Billion), 2002-2005
Figure 4-10: Worldwide Drug Discovery Expenditure ($ Billion), 2002 & 2006
Figure 4-11: Revenues for Selected Drug Discovery related Products ($ Million), 2000 & 2005
Figure 4-12: Investment Trends in IT Tools in Bio-Informatics Industry ($ Billion), 2005 & 2010
Figure 4-13: Worldwide Market of IT Tool Suppliers and Providers in Bioinformatics (%), 2005
Figure 4-14: Worldwide Market of Servers, Storage Devices & Services (US $ Million), 2000-2004
Figure 4-15: Biotech Companies Investment Ratio (%)
Figure 4-16: Venture Capitalist Investment Ratio in Bioinformatics (%)
Figure 4-17: World Bioinformatics Market by Geographical Segmentation (%), 2010
Figure 4-18: Revenue Share of Analysis Software and Services Segment in Bioinformatics ($ Billion), 2005 & 2010
Figure 5-1: Global Market For Nanotechnology Applications in the Bioinformatics ($ Billion), 2005 & 2010
Figure 5-2: Market Share of Nanotechnology in Bio-Informatics by NanoComponents (%), 2004
List of Tables:
Table 8-1: Accelrys Inc. - Financial Statistics (2003-2005)
Table 8-2: ACLARA BioSciences, Inc. - Financial Statistics (2002-2004)
Table 8-3: Affymetrix - Financial Statistics (2002-2004)
Table 8-4: Agilent Technologies Inc. - Financial Statistics (2002-2004)
Table 8-5: Amersham Biosciences Limited - Financial Statistics (2002 & 2003)
Table 8-6: Applied Biosystems Group - Financial Statistics (2003-2005)
Table 8-7: Ciphergen Biosystems Inc. - Financial Statistics (2002-2004)
Table 8-8: CuraGen Corporation - Financial Statistics (2002-2004)
Table 8-9: Gene Logic - Financial Statistics (2002-2004)
Table 8-10: Illumina Inc. - Financial Statistics (2002-2004)
Table 8-11: InforMax Inc. - Financial Statistics (2001 & 2002)
Table 8-12: Incyte Corporation - Financial Statistics (2002-2004)
Table 8-13: Lion Bioscience AG - Financial Statistics, 2005
Table 8-14: Silicon Graphics, Inc. - Financial Statistics (2003-2005)
Table 8-15: Tripos Inc. - Financial Statistics (2002-2004)